Tags

Type your tag names separated by a space and hit enter

Ivermectin may be a clinically useful anti-inflammatory agent for late-stage COVID-19.
Open Heart. 2020 09; 7(2)OH

Authors+Show Affiliations

Department of Preventive Cardiology, Mid America Heart Insitute, Kansas, Missouri, USA jjdinicol@gmail.com.Clinica Libre de Adicciones, Tijuana, Baja California, Mexico.Catalytic Longevity Foundation, San Diego, California, USA.

Pub Type(s)

Editorial

Language

eng

PubMed ID

32895293

Citation

DiNicolantonio, James J., et al. "Ivermectin May Be a Clinically Useful Anti-inflammatory Agent for Late-stage COVID-19." Open Heart, vol. 7, no. 2, 2020.
DiNicolantonio JJ, Barroso J, McCarty M. Ivermectin may be a clinically useful anti-inflammatory agent for late-stage COVID-19. Open Heart. 2020;7(2).
DiNicolantonio, J. J., Barroso, J., & McCarty, M. (2020). Ivermectin may be a clinically useful anti-inflammatory agent for late-stage COVID-19. Open Heart, 7(2). https://doi.org/10.1136/openhrt-2020-001350
DiNicolantonio JJ, Barroso J, McCarty M. Ivermectin May Be a Clinically Useful Anti-inflammatory Agent for Late-stage COVID-19. Open Heart. 2020;7(2) PubMed PMID: 32895293.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Ivermectin may be a clinically useful anti-inflammatory agent for late-stage COVID-19. AU - DiNicolantonio,James J, AU - Barroso,Jorge, AU - McCarty,Mark, PY - 2020/08/25/accepted PY - 2020/9/8/entrez PY - 2020/9/9/pubmed PY - 2020/9/17/medline KW - anti-oxidants KW - inflammation KW - oxidative stress JF - Open heart JO - Open Heart VL - 7 IS - 2 SN - 2053-3624 UR - https://www.unboundmedicine.com/medline/citation/32895293/Ivermectin_may_be_a_clinically_useful_anti_inflammatory_agent_for_late_stage_COVID_19_ DB - PRIME DP - Unbound Medicine ER -